关键数据
4.810今开
4.810最高
101.05K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.07%换手率
4.750昨收
4.520最低
370.39K成交额
亏损市盈率静
-30.76市净率
0.00%股息率 TTM
-74.88%ROA
7.12052周最高
0.58量比
-61.84M净利润
153.88M总股本
-1.5635每股收益TTM
1.88Beta
-1746.27%ROE
3.22052周最低
6.11%振幅
82.00%毛利率
712.48M总市值
2.56回报/风险
4.60%风险率
操作建议
AVITA Medical Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名72/386位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价7.00。中期看,股价处于上升通道。近一个月,市场表现较强,基本面评分较高,但较强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
AVITA Medical Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Ionis Pharmaceuticals Inc
IONS
26
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
AVITA Medical Inc简介
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
公司代码RCEL
公司AVITA Medical Inc
CEOVance (Cary G)
网址https://www.avitamedical.com/
公司股东
常见问题
AVITA Medical Inc(RCEL)的当前股价是多少?
AVITA Medical Inc(RCEL)的当前股价是 4.76。
AVITA Medical Inc的股票代码是什么?
AVITA Medical Inc的股票代码是RCEL。
AVITA Medical Inc股票的52周最高点是多少?
AVITA Medical Inc股票的52周最高点是7.12。
AVITA Medical Inc股票的52周最低点是多少?
AVITA Medical Inc股票的52周最低点是3.22。
AVITA Medical Inc的市值是多少?
AVITA Medical Inc的市值是727.61M。
现在AVITA Medical Inc(RCEL)的股票是买入、持有还是卖出?
根据分析师评级,AVITA Medical Inc(RCEL)的总体评级为买入,目标价格为7.00。
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是多少
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是-1.74。